Xiangyong J. Li

No. 600 Tianhe Road
Guangzhou, 510000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 77 publications

Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure.

Low-level hepatitis B surface antigen by ECLIA stratifies early relapse risk in patients with interferon-based HBV functional cure.

Journal: Frontiers in immunology

Published: April 24, 2026

Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study.

Efficacy and Safety of Oral NEPA Versus Fosaprepitant Plus Palonosetron for Preventing Chemotherapy-Induced Nausea and Vomiting in Patients with Nasopharyngeal Carcinoma: A Propensity-Score-Matched Retrospective Study.

Journal: Cancers

Published: April 06, 2026

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial.

Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Virus Infection in the High-Replicative Low-Inflammatory Phase: A 48-Week Randomized Controlled Trial.

Journal: Journal of medical virology

Published: November 19, 2025

NSUN2/m5C/TPI1 axis promotes glycolysis and immune evasion in breast cancer.

NSUN2/m5C/TPI1 axis promotes glycolysis and immune evasion in breast cancer.

Journal: Journal of translational medicine

Published: October 11, 2025

Clinical analysis of anti-GT1a antibody-positive Guillain-Barré syndrome in 25 children

Clinical analysis of anti-GT1a antibody-positive Guillain-Barré syndrome in 25 children

Journal: Zhonghua er ke za zhi = Chinese journal of pediatrics

Published: September 17, 2025

Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes.

Dissecting antibody-mediated natural killer cell effects reveals a cytotoxic CX3CR1+KLRC2-CD16hi subset linked to hepatitis B virus outcomes.

Journal: Clinical and molecular hepatology

Published: August 18, 2025

Impaired WNT3/IGF-1 Signaling in Dorsal Dentate Gyrus Contributes to Chronic Pain-Related Cognitive Impairment.

Impaired WNT3/IGF-1 Signaling in Dorsal Dentate Gyrus Contributes to Chronic Pain-Related Cognitive Impairment.

Journal: CNS neuroscience & therapeutics

Published: July 16, 2025

Treatment of patients with hyperthyroidism and liver failure: a retrospective cohort study.

Treatment of patients with hyperthyroidism and liver failure: a retrospective cohort study.

Journal: BMC gastroenterology

Published: May 28, 2025

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.

Tenofovir Alafenamide Fumarate Reduces Virological Replication in HBeAg-Negative Patients With Normal Alanine Aminotransferase: A 48-Week Randomised Controlled Trial.

Journal: Journal of viral hepatitis

Published: May 27, 2025

Implications of LINC01094 for human malignancies.

Implications of LINC01094 for human malignancies.

Journal: PeerJ

Published: April 09, 2025

Corrigendum to: Overexpression of PTEN induces cell growth arrest and apoptosis in human breast cancer ZR-75-1 cells.

Corrigendum to: Overexpression of PTEN induces cell growth arrest and apoptosis in human breast cancer ZR-75-1 cells.

Journal: Acta biochimica et biophysica Sinica

Published: February 19, 2025

Relationship Between Nucleos(t)ide analogue antiviral response time and prognosis in Chronic Hepatitis B: conclusions depend on baseline viral load and HBeAg status.

Relationship Between Nucleos(t)ide analogue antiviral response time and prognosis in Chronic Hepatitis B: conclusions depend on baseline viral load and HBeAg status.

Journal: Frontiers in pharmacology

Published: February 07, 2025

Showing 1-12 of 77

Last Updated: 09/26/2026